The Oncology Institute issues FY2022 results and 2023 guidance; specific numbers not available in filing text

Oncology Institute, Inc.

Slide presentation furnished as Exhibit 99.1 includes financial results for Q4 and FY2022.
Presentation also provides business update and guidance for the year ending December 31, 2023.
Exact revenue, EPS, or other financial figures are not disclosed in the provided filing excerpt.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.